PIN53 - IS THE RECOMBINANT ZOSTER VACCINE ALSO COST-EFFECTIVE FOR THE GERMAN POPULATION ≥50 YEARS OF AGE?

Oct 1, 2018, 00:00 AM

10.1016/j.jval.2018.09.1372

https://www.valueinhealthjournal.com/article/S1098-3015(18)34674-6/fulltext

Section Title :

Section Order : 760

First Page :

https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34674-6&doi=10.1016/j.jval.2018.09.1372

HEOR Topics :

Tags :

Regions :